ViroPharma, Eli Lilly deal

The companies amended a 2004 deal under which VPHM acquired U.S. rights to manufacture and market LLY's Vancocin Pulvules, an oral capsule formulation of the antibiotic vancomycin (see BioCentury, Oc...